Abstract. Ferrocene analogues of known fatty acid amide hydrolase inhibitors and CB2 ligands have been synthesized and characterized spectroscopically and crystallographically. The resulting bioorganometallic isoxazoles were assayed for their effects on CB1 and CB2 receptors as well as on FAAH. None had any FAAH activity but compound 3, 5-(2-(pentyloxy)phenyl)-N-ferrocenylisoxazole-3-carboxamide, was found to be a potent CB2 ligand (Ki = 32.5 nM).
Introduction
N-Arachidonoylethanolamine (AEA), also known as anandamide, is an endogenous signaling mediator of the endocannabinoid system. [1] It is formed from a membrane precursor, termed N-arachidonoyl phosphatidylethanolamine, through multiple biosynthetic pathways. [2, 3] [9 -13] Over recent decades, the development of CB2 ligands and FAAH inhibitors has significantly progressed underpinned by numerous clinical trials of CB2 agonists and FAAH inhibitors for the treatment of pain, inflammation, and central nervous system (CNS)-dependent disorders.[4, 14, 15] Recently, our work has identified 3-carboxamido-5-aryl-isozazole as a versatile scaffold for the design of CB2 ligands 3 or FAAH inhibitors. [16] [17] [18] [19] Of note, compound 1 (ALIAE218, Figure 1 ) showed potent affinity toward CB2 receptors in the nanomolar range and significantly reduced dextran sulfate sodium (DSS)-induced colitis in mice. [16] Interestingly, the change of the pentoxy group of 1 from the ortho to the para position (2, ALIAE247, Figure 1) triggered a biological response switch from a CB2 ligand to a FAAH inhibitor.
Furthermore, the study of 2 in a model of DSS-induced colitis in mice identified its ability to alleviate inflammation. [18] 
Discussion
Ferrocene, known as an organometallic sandwich compound, has been used for drug design due to its suitable lipophilicity (logP = 2.66) facilitating membrane permeability, rotatable aromatic cyclopentadienyl ring conferring conformation diversity, and potential antioxidant capacity as well as its ability to generate reactive oxygen species (ROS) under certain conditions when suitable analogues undergo an activation process. [20] [21] [22] [23] [24] [25] [26] In addition, ferrocene and its derivatives have shown low toxicity in a wide range of tests in mammals (e.g. mice, rats, monkeys). [20] Recently, 4 we have performed the replacement of adamantanyl amine by aminoferrocene on a series of in-house dihydroquinoline-based CB2 ligands. Our study implied that aminoferrocene-based compounds can replace adamantanyl amines in CB2-targeting agents without significantly altering the binding affinity and efficacy of the molecules (Figure 2) . [27] Given this initial success, we wished to expand this concept to other FAAH and CB2 -based systems, namely isoxazoles. We anticipated that the formation of direct ferrocenyl anaolgues of 1 and 2, namely 3 and 4 (vide infra) would suffice in this proof of principle study. 
Results/Methodology.
Accordingly, we continued this research stream with a view to forming 3-carboxamido-5-ferrocenyl-isozazole-based modulators of the endocannabinoid system. These compounds were readily made by standard amide coupling protocols and were fully characterized by proton and carbon NMR spectroscopy, mass spectrometry and by elemental analysis. Analogue 5 was also made, but not tested, as it was an excellent candidate for obtaining solid state crystallization data, proving the presence and connectivity of the ferrocene moiety ( Figure 3 ). cAMP accumulation and inverse agonists that inhibit cAMP production. As illustrated in Table 1 , the replacement of the adamantanyl group of compound 1 (Ki = 36 nM) by a ferrocene unit (3, Ki = 32.5 nM) did not adversely affect its binding affinity toward CB2 receptors. Interestingly, such a replacement improved the efficacy of cAMP formation (Emax from 242% to 400%, EC50 from 1046 nM to 221 nM). This observation is consistent with our previous conclusion that aminoferrocene-based compounds can replace adamantanyl amines in CB2-targeting agents. [27] On the contrary, the introduction of a ferrocene unit to replace the adamantanyl group of compound 2 brought about a complete loss of FAAH inhibition probably due to the steric interaction which is induced by the slightly larger ferrocene unit rather than the adamantanyl group. Piomell and co-workers has studied the structure-activity relationship of carbamate-based FAAH inhibitors, which indicated the bulky groups (e.g., exo-2-norbornyl, adamantanyl) were unfavorable for FAAH inhibition. [31] Therefore, a ferrocene unit may be more sensitive to the steric interaction with FAAH active site in comparison to an adamantanyl group. Experimental.
Chemistry.
Aminoferrrocene was purchased from TCI, UK and used as such. The two isoxazole acid precursors (i.e., 5-(2-pentyloxyphenyl)isoxazole-3-carboxylic acid and 5-(4-pentyloxyphenyl)isoxazole-3-carboxylic acid) were obtained using known synthetic procedures [16] . High resolution mass spectrometry (HRMS) was performed by the EPSRC National Mass Spectrometry Facility, University of Swansea. 5-Methylisoxazole-3-carboxylic acid (127 mg, 1 mmol) was reacted with HOBt (68 mg, 0.5 mmol), HBTU (570 mg, 1.5 mmol) and DIPEA (0.35 mL) in CHCl3 (20 mL).
The reaction mixture was stirred at RT for 45 min. and then aminoferrocene (241 mg, 1.2 mmol) was added and the mixture was stirred for 24 hr. Work up was as above.
An orange band was eluted with a hexane: ethyl acetate (6:4) mixture, which was collected and evaporated to dryness. The yield was 160 mg, 45% of an orange solid.
Crystallization by diffusion between CH2Cl2 and hexane provided orange crystals. 
Conclusion and future perspectives.
There is growing evidence that CB2 inverse agonists can attenuate inflammation and osteoporosis through regulating the migration of immune cells. derivatives. It is anticipated that other GPCR-based or enzyme inhibitor ligands might be designed incorporating a ferrocenyl moiety [34] with the potential for example to assist in X-ray protein studies [35] or to enable further Fe(II)/(III) redox chemistry [36] [37] [38] [39] .
Executive Summary
 It is possible to synthesize ferrocene analogues of known cannabinoid receptor ligands.
 These are characterized in both solution and in the solid state.
 Compound 3 retains binding and displays improved efficacy at the CB2 receptor.
 Ongoing studies are looking at other uses of ferrocenes as bioisosteres in bioorganometallic chemistry.
